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Summary
Myelin, the insulating layers of membrane wrapped
around axons by oligodendrocytes, is essential for
normal impulse conduction. It forms during late
stages of fetal development but continues into early
adult life. Myelination correlates with cognitive devel-
opment and can be regulated by impulse activity
through unknown molecular mechanisms. Astrocytes
do not form myelin, but these nonneuronal cells can
promote myelination in ways that are not understood.
Here, we identify a link between myelination, astro-
cytes, and electrical impulse activity in axons that is
mediated by the cytokine leukemia inhibitory factor
(LIF). These findings show that LIF is released by
astrocytes in response to ATP liberated from axons fir-
ing action potentials, and LIF promotes myelination
by mature oligodendrocytes. This activity-dependent
mechanism promoting myelination could regulate
myelination according to functional activity or envi-
ronmental experience and may offer new approaches
to treating demyelinating diseases.
Introduction
There is growing awareness that activity-dependent in-
teractions between glia and synapses are important
for nervous system development and function (Fields
and Stevens-Graham, 2002; Fields, 2004), but compara-
tively little is known of activity-dependent interactions
between axons and myelinating glia. These glial cells
are far removed from synapses where neurotransmitter
could act as a neuron-glial signal, and the mechanisms
regulating myelination are still unclear. Myelination by
oligodendrocytes in the CNS and Schwann cells in the
PNS is essential for nervous system function in verte-
brates, and myelin organizes the distribution of ion
channels along the axon to provide the electrical proper-
ties necessary for saltatory impulse conduction (Dupree
et al., 2004). Myelination is a highly regulated develop-
mental process, but it also takes place postnatally and
continues into early adult life (Yakovlev and Lecours,
1967; Giedd, 2004). As with synaptic remodeling during
this period, evidence suggests that action potential fir-
ing can influence myelination (Zalc and Fields, 2000; De-
*Correspondence: fieldsd@mail.nih.govmerens et al., 1996). More recent evidence suggests that
activity-dependent effects on myelination may regulate
nervous system function according to functional and
cognitive activity (Schmithorst et al., 2005), learning
(Bengtsson et al., 2005), and environmental input (Mark-
ham and Greenough, 2004). For review see Fields (2005).
How, at a molecular and cellular level, impulse activity
promotes myelination by mature oligodendrocytes, is
an important question.
Two general molecular mechanisms have been re-
vealed for activity-dependent effects on early stages
of myelination: activity-dependent regulation of cell ad-
hesion molecule expression in neurons that are neces-
sary for myelination (Itoh et al., 1995, Stevens et al.,
1998) and the release of diffusible signaling molecules
from axons firing action potentials, which activate re-
ceptors on premyelinating glia and influence their prolif-
eration and differentiation (Fields and Stevens, 2000;
Stevens et al., 2002). Molecular mechanisms for effects
of impulse activity on myelination at later stages of de-
velopment are unknown.
Purinergic signaling, mediated by the activity-depen-
dent release of ATP from axons (Stevens and Fields,
2000) and the subsequent hydrolysis to adenosine (Ste-
vens et al., 2002), is one of the principal mechanisms of
activity-dependent communication between axons and
myelinating glia (Fields, 2006). ATP released from axons
firing action potentials inhibits myelination by Schwann
cells by arresting their development at an early stage
(Fields and Stevens, 2000). In the CNS, adenosine, pre-
sumably generated by the hydrolysis of extracellular
ATP released from axons, inhibits proliferation of oligo-
dendrocyte progenitor cells (OPCs), and stimulates their
differentiation into a premyelinating stage, thus increas-
ing myelination (Stevens et al., 2002). In both cases, ac-
tion potentials influence myelination by regulating matu-
ration of immature premyelinating glia. The possible
activity-dependent communication and effects on oligo-
dendrocytes that are already differentiated to a promye-
linating stage have not been explored.
The object of the present series of experiments was to
determine if neural impulse activity can influence myeli-
nation at later stages of oligodendrocyte development,
independent of the known effects of adenosine on
OPC differentiation (Stevens et al., 2002). An activity-de-
pendent effect on myelination after OPCs have matured
could have relevance to treating demyelinating disease
and to use-dependent effects on myelination. The re-
sults reveal a new mechanism by which action poten-
tials influence myelination. This involves unexpected in-
teractions between astrocytes and myelinating glia and
between purinergic and cytokine signaling.
Results and Discussion
To determine effects of action potentials on myelination
after oligodendrocytes have matured well beyond the
progenitor stage, we conducted experiments in special
culture dishes (Campenot chambers) equipped for elec-
trical stimulation (Figure 1A). After 3–4 weeks in culture,
Neuron
824Figure 1. Action Potentials Stimulate Myeli-
nation of DRG Axons by Mature Oligodendro-
cytes
(A) Mouse DRG neurons were cultured 3–4
weeks in multicompartment culture dishes
equipped with electrodes for stimulating ac-
tion potentials in axons. Axons from DRG
neurons plated into the two-side compart-
ments grow under the barrier with the central
compartment, providing a high resistance
connection for electrical stimulation through
platinum electrodes (Fields et al., 1992). Oli-
godendrocyte progenitor cells (OPCs) were
added to the side compartments and cul-
tured with DRG neurons for 7 days. Electrical
stimulation in a phasic pattern (see Experi-
mental Procedures) was applied to axons
for 2–3 weeks, and the number of myelinated
profiles stained with Sudan black was com-
pared with unstimulated controls.
(B) Electrical stimulation increased myelina-
tion through a mechanism requiring activa-
tion of sodium-dependent action potentials,
as shown by blocking the effects of stimula-
tion in the presence of 1 mM of the sodium
channel blocker tetrodotoxin (TTX).
(C) Treating cultures of mature oligodendro-
cytes and DRG neurons with adenosine (300
mM) or the adenosine receptor agonist
NECA over a wide range of concentrations
failed to increase the number of Sudan-black-stained myelin profiles, but treatment with the ATP receptor agonist 2MeSATP (300 mM) mimicked
the effect of electrical stimulation in increasing myelination by oligodendrocytes (n = 156 cultures, eight independent experiments). ATP is known
to be released by axons firing action potentials (Stevens and Fields, 2000), suggesting that ATP may be an activity-dependent intercellular mes-
senger regulating myelination.
(D) A similar increase in myelination was seen by using immunocytochemical staining with antibodies against myelin oligodendrocyte glycopro-
tein (MOG) to quantify the number of myelin segments/microscope field in unstimulated (1Ca) and stimulated cultures (1Cb) (24 cultures, three
independent experiments). p < 0.005 with respect to control; scale bar = 20 mm. Error bars represent SEM.OPCs were added to DRG neurons and co-cultured to-
gether for 7 days to allow sufficient time for OPCs to dif-
ferentiate to the oligodendrocyte stage. Axons were
then stimulated with a pattern of electrical activity (0.5 s
at 10 Hz, every 2 s), which is known to stimulate release
of ATP from axons (Stevens and Fields, 2000). 2 weeks
later, myelination was assessed and found to have in-
creased 3-fold on axons firing action potentials com-
pared with unstimulted controls, or axons stimulated
in the presence of TTX, which blocks sodium-dependent
action potentials (Figure 1B) (p < 0.001).
Thus, action potential firing in axons can increase
myelination after oligodendrocytes have developed be-
yond the progenitor stage. It would be difficult to explain
this result by previous studies reporting that activity-de-
pendent production of adenosine promotes myelination
by stimulating differentiation of oligodendrocytes. As
expected, adenosine or the adenosine receptor agonist
NECA applied over a wide range of concentrations after
7 days in coculture had no effect on myelination (Fig-
ure 1C). This is consistent with the expectation that aden-
osine treatment would not increase myelination if applied
after the OPCs had matured.
ATP does not stimulate differentiation of OPCs, as
shown in previous studies (Stevens et al., 2002), but sur-
prisingly, treatment of cocultures at this later devel-
opmental stage with a nonhydrolysable form of ATP,
2MeSATP (300 mM), produced significantly more myelin-
ated axons per field visualized by Sudan black staining
(Figure 1C) (ANOVA, p < 0.005) or staining for the myelin
oligodendrocyte glycoprotein (MOG) (Figures 1Ca, 1Cb,and 1D) (p < 0.005). Electrical stimulation combined with
2MeSATP treatment produced no further increase in
myelination, suggesting that electrical activity and ATP
receptor activation may increase myelination by acting
through the same mechanism (Figure 2A). Because
these cultures were treated with ATP receptor agonists
after the oligodendrocytes had already matured to a pro-
myelinating stage, the increased myelination must be
due to effects other than promoting differentiation
from the immature stage, in contrast to the actions of
adenosine (Stevens et al., 2002). (This was confirmed
by staining the cocultures with markers of oligodendro-
cyte differentiation. There was no significant difference
in the proportion of cells stained for NG2, O4, and O1
compared with controls, after treating cocultures with
100 mM 2MeSATP for 2, 4, or 7 days, starting 7 days after
coculturing the OPCs with DRG neurons [Figure 3] [p >
0.3 in all cases]). Cells were post mitotic during the treat-
ment period as shown by measuring mitotic rate with
a BrdU assay, and ATP treatment had no effect on cell
proliferation (Figure 3). The total number of neuron (p >
0.4) and glial cells (p > 0.3) was not significantly different
between controls and ATP-treated cocultures after 14
days, suggesting an effect of ATP receptor activation
on myelination that is unrelated to cell survival or cell
death. Figure 3 provides an independent analysis of
changes in proportion of O1-, MBP-, and MOG-positive
cells in cocultures (n = 280 microscope fields).
There is a large family of ATP receptors (P2 receptors)
that could allow glia to detect ATP release from
axons. (See Burnstock [2004] for review of purinergic
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825receptors.) These receptors activate a wide range of in-
tracellular signaling cascades that could interact with
other axonal signals regulating myelination. Experi-
ments with more selective P2 receptor agonists showed
that the P2Y receptor agonist UTP (300 mM) was ineffec-
tive in increasing myelination (90.1%6 13.9% relative to
control), but the P2X receptor agonist a-b methyl ATP
(300 mM) increased myelination 169.4% 6 37.0%. Con-
siderable additional research will be required to fully
identify the specific P2 receptor subtypes responsible
for this increase in myelination, but these initial findings
do not provide support for involvement of the P2X3,
P2Y2, or P2Y4 receptor subtypes. Further experiments
suggest that ATP released from axons firing action po-
tentials stimulates myelination by mature oligodendro-
cytes through an unexpected mechanism involving
cytokine signaling.
Figure 2. Electrical Activity Stimulates Myelination through a Mech-
anism Involving ATP Receptor Activation and the Cytokine Leuke-
mia Inhibitory Factor
(A) Both electrical stimulation (10 Hz, phasic; 0.5 s pulse every 2 s)
and ATP receptor activation with 300 mM 2MeSATP for 2 weeks in-
creased myelination, with nonadditive effects when used in combi-
nation, suggesting action through a similar mechanism.
(B) Activity-blocking antibodies against the cytokine leukemia inhib-
itory factor (LIF) blocked the increase in myelination produced by
2MeSATP treatment. No effects on myelination were seen after an-
tibody treatment in the absence of 2MeSATP stimulation, suggest-
ing the effects of LIF are activity dependent and require ATP recep-
tor stimulation (93 experiments; three replicates). None of the
treatments affected the number of oligodendrocytes (data not
shown). Asterisk, p < 0.05; double asterisks, p < 0.005. Error bars
represent SEM.Interaction between ATP and LIF Receptor Signaling
in Myelination
A search of the literature for factors that might affect
myelination after OPCs have differentiated to a promye-
linating phenotype suggested possible involvement of
cytokines. Recently published studies demonstrate
a pronounced increase in myelination in cultures of dis-
sociated cerebral cortex, which is proportional to the
concentration of exogenous ciliary neurotrophic factor
(CNTF) or leukemia inhibitory factor (LIF) applied (Stank-
off et al., 2002). The positive effect of these cytokines on
myelination results from effects on late-stage oligoden-
drocytes; specifically those cells expressing MOG,
a cell-surface glycoprotein of mature oligodendrocytes
(Scolding et al., 1989), which is not expressed in oligo-
dendrocytes before 7 days in coculture. Consistent
with this, we observed that the proportion of oligoden-
drocytes staining positively for MOG was increased af-
ter 7 days 2MeSATP treatment begun after 1 week in co-
culture (33%6 0.888% versus 64%6 3.41%; p < 0.001),
but no difference in number of MOG-positive cells was
seen after 2 or 4 days 2MeSATP treatment begun 7
days after coculture. (See also data from a replicate ex-
periment in Figure 3, D11 and D14.) Similar effects were
seen after treating oligodendrocytes in monoculture
with 2MeSATP for seven days (44.8% 6 2.24% versus
22.6% 6 1.19% MOG-positive oligodendrocytes in
treated versus control cultures; p < 0.001), indicating
that the LIF response does not require indirect effects
involving neurons. (It is important to note, in the context
of results to be discussed below, that monocultures of
oligodendrocytes contain approximately 3% GFAP-
positive astrocytes, increasing to 8% by 7 days in
culture.)
To test the hypothesis that ATP might promote myeli-
nation through an LIF-dependent mechanism, we added
antibodies against LIF to cocultures treated with the
ATP receptor agonist 2MeSATP (Figure 2B). The in-
crease in myelin induced by 2MeSATP was blocked by
the presence of antibody blocking LIF activity, but mye-
lination was not affected by antibody against LIF alone.
This indicates that the effects of endogenous LIF on
myelination require activation of P2 receptors. The result
was specific to LIF antibody, as normal goat IgG had
no effect on the increased myelination induced by
2MeSATP, and normal goat IgG had no effect on myeli-
nation in the absence of 2MeSATP (Figure 2B).
This association between ATP receptor activation
and LIF in promoting myelination suggests that action
potential firing could promote myelination by the activ-
ity-dependent release of LIF in cocultures. To test this
hypothesis, we measured the concentration of LIF in
these cultures to determine if LIF was released when
axons were stimulated to fire action potentials. Neurons
and oligodendrocytes were cultured together in multi-
compartment cell culture dishes equipped with platinum
electrodes to stimulate the axons as they traverse the
barrier between central and side compartments (Fig-
ure 1A) (Fields et al., 1992). Axons were stimulated
with a phasic stimulus (0.5 s at 10 Hz every 2 s), and
the culture medium was collected and assayed for LIF
content with an ELISA (R&D Systems Quantikine mu-
rine). Action potential firing significantly increased the
concentration of LIF in cocultures measured after 24 hr
Neuron
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drocytes in Cocultures and Effects of P2-Re-
ceptor Activation
The state of differentiation of oligodendro-
cytes in cocultures was determined by stain-
ing with antibodies against markers of OPC
differentiation after 7, 9, 11, and 14 days in
coculture with DRG neurons in the presence
and absence of 100 mM 2MeSATP, and cell
proliferation was measured by BrdU incorpo-
ration (magenta). Hoechst nuclear stain was
used to identify all cells in the culture (blue)
and to calculate the percentage of cells iden-
tified with each marker. Mean percentage
and SEM of cells stained positively with
each marker are indicated in the lower right
corner of each figure (n = 40 microscope
fields in each). Immunocytochemical staining
for a marker of early oligodendrocytes O4 is
shown in green; a marker for intermediate
stage oligodendrocytes, myelin basic protein
(MBP), is shown in red; and the myelin oligo-
dendrocyte glycoprotein (MOG) expressed
by mature oligodendrocytes is shown in yel-
low. The results show that OPCs have pro-
gressed into a postmitotic phase and begun
to express the O4 antigen in large numbers
by 7 days in culture, the time when treatment
with 2MeSATP was begun. ATP receptor ac-
tivation with 2MeSATP had no effects on mat-
uration or proliferation of oligodendrocytes
when applied after 7 days in coculture, but it
did increase the number of cells expressing
the mature oligodendrocyte marker MOG af-
ter 11 and 14 days (4–7 days 2MeSATP treat-
ment; p < 0.001). The results show that ATP
receptor activation increases myelination by
increasing development of oligodendrocytes
at the mature MOG positive stage, rather than
acting on cells at the progenitor stage.stimulation (Figure 4A). The increase in LIF concentra-
tion in the culture medium declined with prolonged elec-
trical stimulation, but the elevated levels of LIF persisted
for at least one week of electrical stimulation (Figure 4A).
(Tests with purified CNTF confirmed that the ELISA as-
say does not crossreact with the cytokine CNTF.)
There are some discrepancies reported in the litera-
ture on the effects of LIF on myelination. Using similar
cell culture models, Stankoff and colleagues (2002)
showed a significant concentration-dependent increase
in myelination after LIF treatment, but in another study,
treatment of cocultures with LIF was reported to inhibit
myelin formation (Park et al., 2001). This controversy
was investigated and resolved by applying a wide range
of LIF concentrations to cocultures of DRG neurons and
oligodendrocytes after 7 days, and assessing the
amount of myelin formed 14–21 days later. The results
revealed that myelination was increased significantly
by low concentrations of supplemental LIF (<5 ng/ml)
(Figures 4B and 4D) but that high concentrations(>5 ng/ml) were inhibitory (Figures 4C and 4D). Such
nonlinear concentration-response functions are not un-
usual for cytokines in many biological processes. Note
that the concentration of LIF measured in cocultures
treated with 2MeSATP for 24 hr was 0.014 ng/ml, which
is in the optimal range for a positive effect of LIF on mye-
lination.
If the increase in myelination produced by electrical
stimulation was dependent on endogenous LIF released
in response to ATP, which is known to be liberated by
electrically active axons (Stevens and Fields, 2000),
the increase in myelination should be inhibited by elec-
trical stimulation in the presence of antibodies against
LIF. The results confirmed this hypothesis (Figure 5A).
The mechanism responsible for the increase in LIF in
cocultures induced by action potential firing was inves-
tigated and found to depend on activity-dependent ATP
release and ATP receptor activation. Measurements
showed that LIF was released from cocultures in re-
sponse to direct application of 2MeSATP (100 mM), in
Action Potentials Promote Myelination
827Figure 4. Action Potential Firing Causes LIF
Release from Cocultures of DRG Neurons
and Oligodendrocytes, and LIF Treatment Af-
fects Myelination in a Concentration-Depen-
dent Manner
(A) 10 Hz phasic stimulation of DRG axons
(open triangles) increased the concentration
of LIF in medium sampled from cocultures
compared with unstimulated cultures (filled
circles). The stimulus-induced release of LIF
decreased with time in culture, but remained
elevated for approximately 1 week (asterisk,
p < 0.03 at day 7). Antibody against LIF did
not interfere with the LIF release (data not
shown). Error bars represent SEM.
(B) LIF was applied to 7 day old cocultures
over a wide range of concentrations, and
myelination was assessed by Sudan black
and MOG staining. Low concentrations of ex-
ogenous LIF (<5 ng/ml) promoted myelination
(p < 0.003, linear regression). Error bars rep-
resent SEM.
(C) LIF concentrations above 5 ng/ml in-
hibited myelination (p < 0.0001, linear regres-
sion). Error bars represent SEM.
(D) Representative images of cocultures
stained with MOG are shown; the optimal
concentration of LIF was near 0.1 ng/ml.
This suggests that endogenously released
LIF could influence the timing and extent of
myelination. An average of 11 myelinated
segments/microscope field were seen in re-
sponse to 300 mM 2MeSATP. There were no
significant differences in the numbers of oli-
godendrocytes or DRGs in these experi-
ments at the time of myelin quantification.
Bar = 10 mm. Error bars represent SEM.the absence of electrical stimulation (0.674 6 0.171 ver-
sus 13.6 6 1.38 pg/ml LIF; control versus 2MeSATP for
24 hr; p < 0.003). The hypothesis that electrical activity
triggers LIF release by an ATP-receptor-dependent
mechanism was tested and supported by finding that
the release of LIF from electrically stimulated cocultures
was blocked in the presence of the apyrase (30 units/ml),
an enzyme that rapidly degrades extracellular ATP
(Figure 5B). The results suggest that action potentials
stimulate release of ATP from axons, which in turn stim-
ulates LIF release promoting myelination of late-stage
(MOG-positive) oligodendrocytes. This raises the impor-
tant question of how LIF is released in an activity-depen-
dent manner.
Astrocytes Link ATP and LIF Signaling with Impulse
Activity in Axons
The most probable source of LIF in the CNS is from as-
trocytes and microglia. No evidence for microglia could
be found in these cultures by using immunocytochemis-
try for OX42 or tomato lectin staining. Cells positive for
GFAP (a cytoskeletal protein in astrocytes) comprise ap-
proximately 3%–13% of the total cells in cocultures of
DRG neurons and OPCs. The number of GFAP-positive
cells increased with time in coculture (4.55%6 0.468%;
7.5% 6 0.704%; 12.6% 6 0.645%; after 5, 7, and 14
days in vitro, respectively). 2MeSATP treatment did not
affect the number of GFAP-positive cells (7.5% 6 0.7%
versus 9.1% 6 1.1% p > 0.2; 12.6% 6 0.64% versus
12.32% 6 0.68% p > 0.7; control versus 2MeSATPfor 5 and 7 days treatment, respectively). Similarly, elec-
trical stimulation did not affect the number of GFAP-
positive cells in DRG cultures (7.8% 6 1.79% versus
4.8% 6 1.68%, electrical stimulation versus control;
p < 0.02).
Immunocytochemistry (Figure 6A), Western blot
(Figure 6B), and RT-PCR (Figure 6C) provide strong ev-
idence for LIF synthesis in astrocytes. Further experi-
ments showed that electrical activity in axons increased
the level of mRNA for LIF in astrocytes (Figure 6C). This
was determined by coculturing astrocytes on DRG
axons in the central compartment of the Campenot
chamber, which excludes DRG cell bodies (Figure 6D).
Astrocytes isolated from rat were used together with
species-specific PCR primers, to ensure that the LIF
mRNA in these measurements derived from astrocytes,
rather than a possible contaminant from mouse neurons
in the side compartment. 24 hr after axons were stimu-
lated electrically, the level of LIF mRNA in astrocytes
cocultured on DRG axons increased (Figure 6C). This in-
crease in LIF mRNA was inhibited by electrical stimula-
tion in the presence of apyrase, an enzyme that rapidly
degrades extracellular ATP. This inhibition is consistent
with the hypothesis that the increase in LIF mRNA in as-
trocytes growing on electrically active DRG axons is de-
pendent upon release of ATP from axons. Examination
of optic nerve from 10 day old mice confirms the pres-
ence of LIF in glia in vivo during the period of myelination
(Figure 6E). Thus, LIF expression in astrocytes is not an
artifact of cell culture (Figure 6A). Specificity of the
Neuron
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tion via an LIF-Dependent Mechanism with
Astrocytes Providing the Major Source of
LIF in Response to 2MeSATP Treatment
(A) LIF neutralizing antibody blocked both the
2MeSATP and action potential-mediated in-
crease in myelination (ANOVA, p = 0.43, n =
68), suggesting that action potentials and
2MeSATP increase myelination via the same
LIF-dependent mechanism. Error bars repre-
sent SEM.
(B) The release of LIF after 24 hr electrical
stimulation of DRG axons in coculture with ol-
igodendrocytes was blocked by stimulation
in the presence of 30 U/ml apyrase, an en-
zyme that rapidly degrades extracellular
ATP (p < 0.0001, ANOVA among all four
groups; p < 0.05 elect. Stim. versus elect.
Stim. + apyrase). This is consistent with the
hypothesis that ATP released from axons fir-
ing action potentials in turn induces release
of LIF by a mechanism involving activation
of P2 purinergic receptors. Treatment with
apyrase alone had no effect on LIF release.
Error bars represent SEM.
(C) Astrocytes release LIF in response to
2MeSATP treatment in a concentration-de-
pendent manner, with a maximal response
between 100 and 300 mM. Error bars repre-
sent SEM.
(D) To identify the cellular source of LIF in co-
cultures, astrocytes, DRG neurons, and oli-
godendrocytes were cultured separately
and treated with 100 mM 2MeSATP for 1–3
days. In contrast to the large amount of LIF
released by 2MeSATP treatment of astro-
cytes, monocultures of DRG neurons or oli-
godendrocytes released little LIF. The con-
centration of LIF in treated versus untreated cultures of astrocytes was significantly different (0.247 6 0.055 versus 7.21 6 0.049 ng/ml LIF
in control versus 2MeSATP; p < 0.0001). The small amount of LIF released in oligodendrocyte cultures could derive from contaminating
GFAP-positive cells, which increase in oligodendrocyte cultures from 3% to 8% by 10 days in culture. Double asterisks, p < 0.001. Error bars
represent SEM.antibody used for immunocytochemistry was confirmed
by the absence of staining in optic nerve from LIF2/2
mice (Stewart et al., 1992) (Figure 6F).
Activation of P2 receptors on astrocytes has been
shown previously to increase the expression of LIF
mRNA in astrocytes (Yamakuni et al., 2002), but the
present findings are the first to show that ATP induces
release of LIF from astrocytes (Figure 5C) and that action
potentials can initiate this release (Figure 5B). Treatment
with 2MeSATP caused a large increase in LIF concentra-
tion in the culture medium of astrocytes in monoculture
tested after 3 hr to 2 days of 100 mM 2MeSATP treatment
(Figure 5Da) (p < 0.0001). The amount of LIF in condi-
tioned medium showed a concentration-dependent re-
lationship to the concentration of 2MeSATP applied
(Figure 5C). The concentration of LIF in conditioned me-
dium reached a maximum at 100–300 mM 2MeSATP, the
concentration range used in the myelination experi-
ments. In contrast, treatment of purified cultures of oli-
godendrocytes (Figure 5Dc) or DRG neurons (Fig-
ure 5Db) with 2MeSATP produced only very small
increases in LIF. We cannot rule out the possibility that
the small amount of LIF measured in purified cultures
of DRG or oligodendrocytes may originate from the
small number of GFAP-positive cells in these cultures.Indeed, there is correlative evidence suggesting this
possibility. The effect of ATP in increasing the number
of MOG-positive oligodendrocytes after 7 days in mono-
culture, but not at earlier times, parallels the increase in
astrocytes from 3% to 8% and correlates with the
amount of LIF released at these times, although the level
of LIF is much lower than in pure astrocyte cultures.
(4 week old DRG cultures contain 6.3% 6 0.804%
GFAP+ cells, and oligodendrocyte monocultures con-
tain 3.9%6 0.454% GFAP+ cells after 2 days in culture.)
Another consideration favoring astrocytes as the pri-
mary source of LIF, rather than DRG neurons, is that
the presence of LIF in DRG neurons under normal condi-
tions is controversial. Although DRG neurons can ex-
press LIF after axotomy, there is little evidence that sig-
nificant levels of LIF are expressed in DRG axons during
myelination (Banner and Patterson, 1994). Similarly for
oligodendrocytes, LIF has been reported in a trans-
formed cell line derived from oligodendrocytes (Mey
and Henkes, 2002), but the presence of LIF in oligoden-
drocytes under normal conditions is not well studied. In
comparison with the large amount of LIF released from
astrocytes after treatment with 2MeSATP, the possible
contribution of LIF from DRG neurons or oligodendro-
cytes would appear minimal.
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by an LIF-Dependent Mechanism
Correlative data showing an association between astro-
cytes and myelination in culture and during development
are consistent with the conclusions from the present se-
ries of studies. The increase in GFAP-positive cells seen
Figure 6. LIF Is Synthesized by Astrocytes and Regulated by Action
Potential Firing
(A) Astrocytes from E19 rat cortex stained strongly with anti-LIF an-
tibody. DRG neurons and oligodendrocytes showed only weak
staining with anti-LIF antibody, and astrocytes from LIF2/2 mice
were not stained (data not shown).
(B) Western blot analysis confirmed the immunostaining results and
indicated astrocytes as the predominant source of LIF in cocultures.
(No microglia were detectable by immunocytochemistry.) Equal
concentrations of protein (35 mg) from purified cultures of DRG neu-
rons, astrocytes, and oligodendrocytes were compared. Antibody
against ankyrin G was used as a control for equal loading in each
lane. Purified mouse LIF confirmed the specificity of the LIF antibody
and indicated that the amount of LIF in the astrocyte sample ex-
ceeds 20 ng.
(C) The level of LIF mRNA in astrocytes grown on DRG axons was in-
creased after 24 hr electrical stimulation of axons (top). This increase
was prevented by stimulation in the presence of apyrase (30 U/ml),
which degrades extracellular ATP (bottom). This indicates that the
activity-dependent regulation of LIF mRNA levels in astrocytes oc-
curs through a mechanism involving P2 purinergic receptor activa-
tion by ATP released from axons firing action potentials.
(D) The experiments on effects of action potential firing on LIF mRNA
in astrocytes were performed in multicompartment cell-culture
chambers that separate the DRG cell bodies from axons. Astrocytes
were derived from rats and plated onto mouse axons in the central
compartment. Species-specific primers for LIF were used to ensure
that the measurements did not derive from LIF mRNA possibly synthe-
sized by neurons. As a control, PCR for 28s ribosomal RNA showed
no change after any of the treatments in (C) (data not shown).
(E) LIF is present in glia in vivo during the period of myelination in
mouse optic nerve, as indicated by immunocytochemical staining of
optic nerve from 10 day old mice.
(F) Specificity of the antibody is shown by the lack of staining in LIF2/2
mice.during development correlates with the normal develop-
mental period of myelination in spinal cord (Dziewulska
et al., 1999), and experimental studies in cell culture
show that astrocytes induce oligodendrocytes to align
their processes with axons (Meyer-Franke et al., 1999).
We therefore tested directly whether astrocytes pro-
moted myelination of DRG axons by oligodendrocytes.
Cocultures of DRG neurons and oligodendrocytes,
which normally contain 3% astrocytes, were supple-
mented with 5% to 15% astrocytes (relative to total
number of oligodendrocytes plated), and myelination
was compared after 2–3 weeks. The results showed
a potent effect of astrocytes in promoting myelination
(Figure 7A). Cocultures made from O1-positive oligo-
dendrocytes obtained by immunopanning to remove as-
trocytes and immature oligodendrocytes, showed no
increase in myelination after treatment with 100 mM
2MeSATP (Figure 7B). This evidence showing that astro-
cytes are essential for the ATP effect on myelination is
consistent with the evidence that ATP acts to increase
myelination by stimulating release of LIF from astro-
cytes. This was verified by adding 8% astrocytes to
the cocultures made from O1+ oligodendrocytes and
finding that this rescued the effect of 2MeSATP treat-
ment in promoting myelination (Figure 7B). In addition,
this experiment with immunopurified O1+ stage oligo-
dendrocytes provides further evidence that ATP acts
by stimulating myelination of mature oligodendrocytes,
rather than promoting differentiation of immature cells,
because these cocultures were made with oligodendro-
cytes after maturation to the O1+ stage, and LIF pro-
moted myelination of these cocultures lacking immature
oligodendrocytes (Figure 7B).
To further test whether the effect of astrocytes in stim-
ulating myelination was due to LIF release from astro-
cytes, we performed experiments with astrocytes
derived from mice with the LIF gene disrupted (Fig-
ure 7A). The effect of astrocytes in promoting myelina-
tion of wild-type DRG axons was completely blocked
by supplementing cocultures with astrocytes derived
from homozygous LIF2/2mice (Stewart et al., 1992) (Fig-
ure 7A). The loss of activity in astrocytes from LIF2/2
mice in promoting myelination could be rescued by
supplementing the cultures with recombinant rat LIF
(0.1 ng/ml) (Figure 7B).
Summary and Conclusions
These experiments reveal several important new inter-
actions between different types of cells (neurons and
two types of glia) and between different signaling sys-
tems (purinergic and cytokine signaling) in the CNS.
They are the first to report that ATP can increase myeli-
nation, that synthesis and release of LIF from astrocytes
is stimulated by action potential firing, that interactions
between purinergic receptor signaling and cytokine sig-
naling occurs in astrocytes, and that this can involve as-
trocytes in the process of myelination according to func-
tional activity in axons.
Taken together, these results reveal a new mechanism
by which electrical activity promotes myelination of CNS
axons at a later developmental stage and possibly into
postnatal life. This process is mediated by ATP receptor
activation, rather than adenosine receptor activation,
and it acts through different molecular and biological
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adenosine in promoting myelination by stimulating
OPC differentiation (Stevens et al., 2002). Electrical ac-
tivity in premyelinated axons increases myelination after
OPCs mature to a promyelinating stage by the activity-
dependent release of ATP from axons, which acts in a
paracrine manner on astrocytes to release LIF and stim-
ulate myelination at this later stage of development.
Figure 7. Astrocytes Promote Myelination in Response to ATP Re-
ceptor Stimulation by Releasing LIF
(A) A positive effect of astrocytes on myelination was show by sup-
plementing cocultures of DRG neurons and oligodendrocytes with
astrocytes. Myelination after 2 weeks in coculture increased in pro-
portion to the percentage of additional astrocytes added 3 hr after
plating OPCs on DRG neurons (solid dots). Similar effects were
seen in cultures supplemented with astrocytes from mice heterozy-
gous for LIF (open circle). However, supplementing cultures with as-
trocytes derived from homozygous LIF2/2 mice failed to increase
myelination (solid triangle). The inability of astrocytes from LIF2/2
mice to increase myelination could be restored by adding 0.1 ng/
ml LIF to the cultures (open triangle) (n = 1200 microscope fields). Er-
ror bars represent SEM.
(B) Eliminating astrocytes from cultures also eliminates the positive
effect of 2MeSATP on myelination. This was shown by making co-
cultures from O1+ oligodendrocytes purified by immunopanning.
Cultures made from mature O1+ oligodendrocytes were still respon-
sive to LIF, as shown by the increase in myelination produced by
adding 0.1 ng/ml LIF to these cultures. The positive effect of
100 mM 2MeSATP on myelination could be restored by supplement-
ing these cocultures of O1-positive oligodendrocytes with 8% astro-
cytes, strongly implicating astrocytes as the primary source of LIF in
response to electrical stimulation causing the release of ATP from
axons. Double asterisks, p < 0.001; n = 400 microscope fields. Error
bars represent SEM.The link between electrical activity and LIF release by
activation of P2 receptors may have relevance to other
developmental processes such as survival or differenti-
ation of neurons and glia (e.g., Mayer et al., 1994; Barres
and Raff, 1993) and possible interaction with immune
system responses involving this cytokine, for example
in multiple sclerosis (Butzkueven et al., 2002). Because
high levels of LIF are detrimental to myelination, impulse
activity could, under certain pathological conditions ac-
companied by high levels of cytokines (or ATP), inhibit
myelination or remyelination rather than stimulate it.
These new findings may provide novel approaches
to understanding and treating myelin disorders in the
CNS after OPCs have matured to the promyelinating
stage. Alexander disease, for example, is a fatal white
matter disorder of childhood caused by mutations in
the GFAP gene (Johnson 2002; Li et al., 2002). Astro-
cytes of these patients exhibit a characteristic abnormal
morphology, but the reasons for white matter abnormal-
ities in Alexander disease are not understood. A possi-
ble link between GFAP abnormalities in astrocytes and
myelination is provided by the present findings implicat-
ing astrocytes in activity-dependent myelination.
These new findings help resolve previous unexpected
observations from studies of genetically modified mice.
Unexpectedly, myelin formation is impaired in LIF2/2
mice in the absence of effects on neuronal survival
(Bugga et al., 1998). An equally surprising phenotype is
seen in mice carrying a null mutation in the cytoskeletal
protein GFAP in astrocytes. These mice develop abnor-
mal myelination (Liedtke et al., 1996), even though astro-
cytes do not form myelin. The physiological basis for this
phenotype is not understood, but this result was inter-
preted by the authors as evidence that the cytoskeletal
protein GFAP is essential for local secretion of an un-
known factor by astrocytes that promotes myelination
by oligodendrocytes (Liedtke et al., 1996). The present
findings would suggest that the unknown substance
could be LIF secreted in response to ATP liberated by
axons firing action potentials. These findings unite pu-
rinergic and cytokine signaling through an activity-de-
pendent mechanism, and they provide a reasonable ex-
planation integrating these two previously separate
observations on myelination in vivo from genetic manip-
ulation of the cytokine LIF and the astrocytic protein,
GFAP.
Experimental Procedures
Cell Culture and Electrical Stimulation
DRG neurons were dissected from the spinal cords of embryonic
day (E) 13.5 mice as described (Stevens et al., 1998). Neurons
were grown for w4 weeks in MEM medium supplemented with N3
containing 100 ng/ml of nerve growth factor and 5% heat-inacti-
vated horse serum in the side compartment of three-compartment
chambers equipped with stimulating electrodes (Fields et al.,
1992). Mitosis of nonneuronal cells was inhibited by a 4 day treat-
ment with 13 mg/ml fluoro-20-deoxyuridine (FUDR) beginning 1 day
after plating. These cultures can be maintained indefinitely with
half-volume changes of medium every 3 days.
Primary cultures of OPCs were obtained from cerebral cortices of
E19–E20 rats or mice and plated into 75 cm2 tissue culture flasks.
The resulting cultures were maintained at 5% CO2 at 37ºC in medium
containing 10% fetal bovine serum (Hyclone). After 11 days in cul-
ture, the flasks were shaken at 37ºC for 3 hr to kill nonglial cells,
and then the medium was changed, and the flasks shaken overnight
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pended, and incubated in an uncoated culture dish for 30 min to en-
rich the population for OPCs. Contaminating cells, primarily endothe-
lial cells, astrocytes, macrophages, and microglia adhere strongly
to the plastic and can be separated out by this panning method.
For some experiments, O1-positive oligodendrocytes were obtained
by immunopanning (Gard and Pfeiffer, 1989). Immunocytochemistry
confirmed that these were mature oligodendrocytes without con-
taminating astrocytes or NG2-positive cells.
Astrocytes were obtained from cerebral cortices of E19–E20 rats
or mice. After oligodendrocytes were isolated, the flasks (above)
were shaken for 2 days to remove floating cells and cell debris. Ad-
herent astrocytes were removed by 0.25% trypsin (5 min at 37ºC)
and plated in 35 mm dishes or multicompartment cultures as re-
quired.
For myelinated cocultures, purified OPCs (>90% OPCs) were
counted and plated on 3 to 4 week old DRG cultures at a density
of 40,000 cells per side compartment. After 3–4 hr, the media was re-
moved and replaced with differentiating media (DMEM + N1 + 0.5%
FBS [Stevens et al., 2002]). 7 days later, cultures were treated with
purinergic agonists and antagonists.
Action potentials were induced in DRG axons by 200 ms 5 V bi-
phasic pulse through platinum electrodes in three-compartment
chambers (Fields et al., 1992). Only those axons growing into the
central compartment beneath the high-resistant barriers are stimu-
lated by this method. 10 Hz phasic (0.5 s at 10 Hz every 2 s) stimulus
patterns were used.
Pharmacological Treatment
ATP, adenosine, 2MeSATP, a-b methyl ATP, and UTP were obtained
from Tocris. Adenosine, N’-Benzyl-50-N-ethylcarboxamidoadeno-
sine (NECA), apyrase, and TTX were obtained from Sigma. Antibody
against mouse LIF was from R&D Systems, and human LIF was from
Alomone. Cultures were treated with fresh agonist or antagonist so-
lutions every 2–3 days for 2 weeks.
Sudan Black Stain for Compact Myelin
After 4% paraformaldehyde fixation, cultures were washed with PBS
and postfixed for 1 hr with 0.1% osmium tetroxide. After two washes
with PBS, the cultures were dehydrated with an ethanol series (25%,
50%, 70%) for 10 min each and incubated for 2 hr in a 0.5% Sudan
black solution in 70% ethanol and washed three times in 3% ethanol
and rehydrated in PBS. Nuclei were stained with Hoechst stain
(1:2000) in PBS for 10 min.
Immunocytochemistry
Cells were fixed with 4% paraformaldehyde for 5 min and washed
three times in PBS. Nonspecific protein binding was blocked with
3% NGS, 0.1% Triton X-100 for 1 hr at RT. The following primary an-
tibodies were used in overnight incubations at 4ºC: anti-NG2 (Chem-
icon, 1:1000), anti-O4 (Chemicon, 1:1000), anti-O1 (Chemicon,
1:500), anti-GFAP (Dako, Carpinteria, CA, 1:2000), anti-MBP (Stern-
berger Monoclonals, 1:1000), anti-OX-42 (Serotec, Oxford, UK), and
anti-mouse LIF (R&D Systems, 1:200). Anti-MOG antibody was
kindly provided by Dr. Barres (Stanford University). FITC- and Rho-
damine-conjugated secondary antibodies against the appropriate
species were applied for 30 min at RT and viewed by epifluores-
cence or confocal microscopy. Similar procedures were used for im-
munocytochemical staining of mouse optic nerve after 4% parafor-
maldehyde fixation and cryosectioning. Cultures were rinsed in PBS,
treated with 0.02% sodium azide in PBS to prevent internalization of
lectin, and incubated in 0.02 mg/ml FITC labeled tomato lectin
(Sigma) for 30 min at RT and fixed with 4% paraformaldehyde to vi-
sualize microglia.
Quantification of Myelin and Cell Numbers
The number of Sudan-black-positive or MOG-positive myelin pro-
files was counted by observers without knowledge of the treatment
condition. Ten or more random fields were selected from each cul-
ture dish or side compartment of the Campenot chamber, and the
total number of myelin profiles and Hoechst-positive nuclei in each
field was recorded. Statistical analysis was performed by using Mini-
tab software with the significance of differences tested by ANOVA
and errors reported as SEM.LIF Assay
Conditioned media was collected from cultures of DRG neurons, ol-
igodendrocytes, astrocytes, and cocultures of DRG neurons and ol-
igodendrocytes. The conditioned media from approximately eight
cultures was collected, flash frozen, and subsequently concentrated
with glycerine-coated Microsep tubes (Pall Life Sciences) to a vol-
ume of approximately 100 ml. At least two replicate 50 ml aliquots
from each sample were assayed for LIF content on ELISA plates ac-
cording to the manufacturer’s instructions (R&D Systems). LIF con-
centration values were obtained by linear regression of absorbance
readings made with a microtiter plate reader, against known con-
centrations of LIF measured in serial dilution on each microtiter
plate. The ELISA does not cross react with other cytokines, and
our tests confirmed no cross reactivity with CNTF, a closely related
cytokine to LIF.
Western Blot Analysis
Western blot was performed for the analysis LIF in DRG neurons, as-
trocytes, and oligodendrocytes. The cells were washed with PBS
and lysed by adding M-PER mammalian protein extraction reagent
(Pierce, Rockford, IL). Protein concentration was determined by
Coomassie protein assay kit (Pierce, Rockford, IL). Electrophoresis
was performed on 14% or 10%–20% gradient polyacrylamide gels
(Invitrogen, Carlsbad, CA). As a positive control, recombinant
mouse LIF (Chemicon) was used. Proteins were transferred to Im-
mobilon transfer membranes (Millipore, Bedford, MA), and blots
were blocked with 5% skim milk in 0.1% tween-20 tris buffer
(TBST) overnight at 4ºC. The blots were probed with anti-mouse
LIF antibody (R&D Systems, Inc., Minneapolis, MN, 1:5,000) and
anti-AnkyrinG antibody (Zymed Lab, Inc., 1:1,000) as a loading con-
trol overnight at 4ºC, followed by horseradish peroxidase (HRP)-
coupled donkey anti-goat secondary antibody (Chemicon) and
sheep anti-mouse (Amersham Biosciences Buckinghamshire, UK).
Blots were analyzed by ECL plus Western blotting detection system
(Amersham Biosciences).
RNA Preparation and RT-PCR
Rat astrocytes were prepared as described above and plated onto
axons of 3 to 4 week old cultures of DRG neurons 3 days prior to
electrical stimulation in Campenot chambers. Medium was replaced
with serum and NGF-free media 12 hr prior to electrical stimulation;
30 U/ml of apyrase was added if appropriate. DRG axons were elec-
trically stimulated with a phasic pattern at 10 Hz for 24 hr. Total RNA
was prepared by the TRIzol (Invitrogen) extraction method with
modifications (Lee et al., 2004). cDNA was prepared from 2 mg total
RNA with Superscript II (Invitrogen) according to manufacturer’s in-
structions. PCR reactions were carried out by Platinum PCR super-
mix high fidelity (Invitrogen) for 35 cycles, and reaction products an-
alyzed on a 2% TAE agarose gel, visualized with SYBR I green
staining (Invitrogen).
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